drugset / Trial / NCT05656573
CART-PSMA Cells for Advanced Prostate Cancer
NaSequentialOpen-labelTreatment
Summary
This is a single center, open-label phase 1 study to assess the safety and feasibility of PSMA-specific CAR modified autologous T cells (CART-PSMA cells) in patients with advanced prostate cancer.
Timeline
- Start
- 2023-03-01
- Primary completion
- 2025-12-01
- Completion
- 2025-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CART-PSMA cells | Cell therapy | 1e+07 unknown | — |
| Subject | CART-PSMA cells | Cell therapy | 1e+08 unknown | — |